Logo
x

Search

Subscribe Now

european commission

Unlocking Approval: Sofie Berg from AbbVie in an Illuminating Dialogue Exchange with PharmaShots

Unlocking Approval: Sofie Berg from AbbVie in an Illuminating Dialogue Exchange with PharmaShots

  • September 23, 2024
MorphoSys and Incyte's Minjuvi (tafasitamab) + Lenalidomide Receive EC's Approval for the Treatment of R/R DLBCL

MorphoSys and Incyte's Minjuvi (tafasitamab) + Lenalidomide Receive EC's Approval for the Treatment of R/R DLBCL

  • August 27, 2021
BMS' Onureg (azacytidine) Receives EC's Approval for as Frontline Oral Maintenance Therapy for Adults with Acute Myeloid Leukemia

BMS' Onureg (azacytidine) Receives EC's Approval for as Frontline Oral Maintenance Therapy for Adults with Acute Myeloid Leukemia

  • June 21, 2021
PharmaShots Interview: Ipsen's Dr. Med. Steven Hildemann Shares Insight on the EC's Approval of Cabometyx + Nivolumab for Advanced Renal Cell Carcinoma

PharmaShots Interview: Ipsen's Dr. Med. Steven Hildemann Shares Insight on the EC's Approval of Cabometyx + Nivolumab for Advanced...

  • May 11, 2021
Roche's Tecentriq Receives EC's Approval as 1L Treatment for Metastatic Non-Small Cell Lung Cancer

Roche's Tecentriq Receives EC's Approval as 1L Treatment for Metastatic Non-Small Cell Lung Cancer

  • May 5, 2021
Biocon Biologics and Viatris Receive European Commission Approval for Abevmy (biosimilar- bevacizumab)

Biocon Biologics and Viatris Receive European Commission Approval for Abevmy (biosimilar- bevacizumab)

  • April 27, 2021
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.